Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-25-009136
Filing Date
2025-02-03
Accepted
2025-02-03 08:49:05
Documents
1
Period of Report
2025-01-11

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4019
  Complete submission text file 0001213900-25-009136.txt   5453
Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Issuer) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INMED PHARMACEUTICALS INC. SUITE 310 - 815 HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address
HULL ANDREW (Reporting) CIK: 0001818252 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39685 | Film No.: 25580764